ArticleMolecular cancer research : MCR2024

NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.

Katelyn J Noronha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.